TrustCore Financial Services’s Charles River Laboratories CRL Stock Holding History

TrustCore Financial Services’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$21.8K	Sell	100 -72	-42%	-$15.7K	﹤0.01%	592
2022 Q3	$34K	Buy	172 +72	+72%	+$15.5K	﹤0.01%	514
2022 Q2	$21K	Hold	100	–	–	﹤0.01%	626
2022 Q1	$28K	Buy	+100	New	+$30.8K	﹤0.01%	583
2021 Q4	–	Sell	-100	Closed	-$41K	–	952
2021 Q3	$41K	Hold	100	–	–	﹤0.01%	519
2021 Q2	$37K	Hold	100	–	–	﹤0.01%	518
2021 Q1	$29K	Hold	100	–	–	﹤0.01%	530
2020 Q4	$25K	Hold	100	–	–	﹤0.01%	521
2020 Q3	$23K	Buy	+100	New	+$20.8K	﹤0.01%	487

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TrustCore Financial Services's CRL Position: Q4 2022 in Review

TrustCore Financial Services reduced its Charles River Laboratories (CRL) stake by 42% in Q4 2022, selling an estimated $15.7K and leaving 100 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #592.

TrustCore Financial Services first reported a position in CRL in Q3 2020 and has held it in 9 quarters since. The position peaked at $41K in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q4 2022.

TrustCore Financial Services held 100 shares of Charles River Laboratories worth $21.8K as of Q4 2022.
TrustCore Financial Services sold 72 Charles River Laboratories shares in Q4 2022, an estimated $15.7K.
Charles River Laboratories made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #592 holding.
TrustCore Financial Services first reported a position in Charles River Laboratories in Q3 2020 and has held it in 9 quarters since.
TrustCore Financial Services's Charles River Laboratories position peaked at $41K in Q3 2021.
627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.